Patent · US Active

2,4,6-trisubstituted pyrido(3,2-d)pyrimidines useful for treating viral infections

US8536187B2 · kind B2 · utility

11Cited by

10References

23Claims

0Family size

Assignee

Gilead Sciences, Inc. · US

Inventors

Eda Canales · San Mateo, US
Lee S. Chong · Newark, US
Michael O' Neil Hanrahan Clarke · Redwood City, US
Scott E. Lazerwith · Foster City, US
Willard Lew · San Mateo, US
Qi Liu · Beijing, CN
Michael L. Mitchell · Union City, US
William J. Watkins · Saratoga, US
Jennifer R. Zhang · Union City, US

Key dates

Filing date	Jul 1, 2009
Grant date	Sep 17, 2013
Priority date	—
Expiry date	Jul 1, 2029

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P39/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pyrido(3,2-d)pyrimidine derivatives represented by the structural formula (Ia): wherein, R1, R2 and R3 are defined herein, pharmaceutical acceptable addition salts, stereochemical isomeric forms, N-oxides, solvates and pro-drugs thereof, for use in the treatment of hepatitis C.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.